Cancer Pain
📧 Sign up to get email alerts when something new happens for Cancer Pain.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2018-09-18FDA Approved: METHADONE HYDROCHLORIDE — Supplemental Application (Elite Laboratories, Inc.)
FDA approved a supplemental application for Elite Laboratories' methadone hydrochloride (ANDA 210484), authorizing its continued marketing a…
-
FDA approval · 2018-09-18FDA Approved: MORPHINE SULFATE EXTENDED RELEASE — Supplemental Application (Rhodes Pharmaceuticals L. P.)
FDA approved a supplemental application for Morphine Sulfate Extended Release from Rhodes Pharmaceuticals L.P., updating the product under a…
-
CLINICAL_TRIALS trial_result · 2018-04-23Clinical Trial Update: Sativex® for Relieving Persistent Pain in Participants With Advanced Cancer [Phase 3]
Phase 3 trial results for Sativex (nabiximols) assessing relief of persistent pain in participants with advanced cancer, with results posted…
-
CLINICAL_TRIALS trial_result · 2017-06-09Clinical Trial Update: Coaching to Improve Care of Cancer Pain [NA]
Clinical trial update indicating completion of a study evaluating coaching to improve care of cancer-related pain.
-
FDA approval · 2017-05-26FDA Approved: MORPHINE SULFATE — Supplemental Application (Actavis Pharma, Inc.)
FDA approved a supplemental application for Morphine Sulfate from Actavis Pharma, Inc., permitting continued marketing of the generic produc…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2017-05-19FDA Approved: MORPHINE SULFATE — Supplemental Application (Amneal Pharmaceuticals of New York LLC)
FDA approved a supplemental application for Morphine Sulfate by Amneal Pharmaceuticals of New York LLC under ANDA 200411, granting a supplem…
-
CLINICAL_TRIALS trial_result · 2017-04-26Clinical Trial Update: Validation and Assessment of Patient Adherence to Opioids for Cancer Pain Using MMAS 8 Pain Clinic
Completed clinical trial from Tata Memorial Centre evaluating validation and patient adherence to opioid therapy for chronic cancer pain usi…
-
FDA approval · 2016-12-16FDA Approved: MS CONTIN — Supplemental Application (Rhodes Pharmaceuticals L.P.)
The FDA approved a supplemental application for MS CONTIN (morphine sulfate) submitted by Rhodes Pharmaceuticals L.P. This action confirms t…
-
FDA approval · 2016-12-16FDA Approved: MORPHINE SULFATE — Supplemental Application (Fresenius Kabi, USA LLC)
FDA has approved a supplemental application for Morphine Sulfate submitted by Fresenius Kabi, USA LLC under NDA204223.
-
FDA approval · 2016-11-04FDA Approved: FENTANYL SYSTEM — Original Application (ALVOGEN)
The FDA has approved ALVOGEN's FENTANYL SYSTEM as an original-application generic product.
-
CLINICAL_TRIALS trial_result · 2016-11-04Clinical Trial Update: To Demonstrate Equivalence in Analgesic Efficacy & Bowel Function Between OXN PR Higher Dose & Lower Dose Tablet Strengths in Subjects With Non-cancer or Cancer Pain [Phase 2, Phase 3]
Phase 2/3 study evaluating whether higher-dose OXN PR is equivalent to lower-dose OXN PR in pain relief and bowel function in patients with …
-
CLINICAL_TRIALS trial_result · 2016-10-31Clinical Trial Update: Analgesic Treatment for Cancer Pain in South East Asia
This document reports the completion of a clinical trial evaluating an analgesic treatment for cancer-related pain in Southeast Asia. The re…
-
FDA approval · 2016-09-30FDA Approved: FENTANYL — Supplemental Application (Aveva Drug Delivery Systems Inc.)
FDA approved a supplemental application for fentanyl submitted by Aveva Drug Delivery Systems Inc., reflecting an approved change to the pro…
-
FDA approval · 2016-08-22FDA Approved: FENTANYL — Supplemental Application (Aveva Drug Delivery Systems Inc.)
FDA approved a supplemental application for fentanyl submitted by Aveva Drug Delivery Systems Inc.
-
CLINICAL_TRIALS research · 2016-08-04Clinical Trial Update: Long-term Effects of Methadone for Cancer Pain
An update on a clinical trial evaluating the long-term effects of methadone for cancer-related pain, sponsored by Hospices Civils de Lyon.
-
FDA approval · 2016-04-20FDA Approved: FENTANYL — Supplemental Application (Aveva Drug Delivery Systems Inc.)
The FDA approved a supplemental application for fentanyl from Aveva Drug Delivery Systems Inc., indicating regulatory action related to a ne…
-
FDA approval · 2016-04-20FDA Approved: FENTANYL TRANSDERMAL — Supplemental Application (SpecGx LLC)
FDA approved a supplemental application for FENTANYL TRANSDERMAL by SpecGx LLC, a generic fentanyl transdermal patch.
-
CLINICAL_TRIALS trial_result · 2016-03-08Clinical Trial Update: Acetaminophen for Cancer Pain [Phase 3]
A Phase 3 trial evaluating acetaminophen for cancer-related pain has completed.
-
CLINICAL_TRIALS trial_result · 2015-12-31Clinical Trial Update: IncobotulinumtoxinA for Treatment of Focal Cancer Pain After Surgery and/or Radiation [Phase 2]
Phase 2 trial of incobotulinumtoxinA for focal cancer pain after surgery and/or radiation. The study was terminated and results were posted …
-
CLINICAL_TRIALS trial_result · 2015-11-20Clinical Trial Update: RCT Comparing the Analgesic Efficacy of 4 Therapeutic Strategies Based on 4 Different Major Opioids (Fentanyl, Oxycodone, Buprenorphine vs Morphine) in Cancer Patients With Moderate/Severe Pain, at the Moment of Starting 3rd Step of WHO Analgesic Ladder. [Phase 4]
Phase 4 randomized trial compares analgesic efficacy of four opioid strategies (fentanyl, oxycodone, buprenorphine, morphine) for moderate-t…
-
FDA approval · 2015-09-11FDA Approved: FENTANYL — Supplemental Application (Aveva Drug Delivery Systems Inc.)
FDA approved a supplemental application for fentanyl from Aveva Drug Delivery Systems Inc., granting approval for an additional formulation/…
-
FDA approval · 2015-09-10FDA Approved: OXYCONTIN — Supplemental Application (Purdue Pharma LP)
FDA approved a supplemental application for OXYCONTIN (oxycodone hydrochloride) submitted by Purdue Pharma LP.
-
CLINICAL_TRIALS trial_result · 2015-07-28Clinical Trial Update: Magnesium Associated With Morphine for Cancer Pain Relief [NA]
A completed clinical trial from the Federal University of São Paulo evaluated magnesium in combination with morphine for cancer-related pain…
-
FDA approval · 2015-06-26FDA Approved: FENTANYL TRANSDERMAL — Supplemental Application (SpecGx LLC)
FDA approved a supplemental application for fentanyl transdermal submitted by SpecGx LLC.
-
FDA approval · 2015-06-26FDA Approved: FENTANYL — Supplemental Application (Aveva Drug Delivery Systems Inc.)
FDA approved a supplemental application for fentanyl submitted by Aveva Drug Delivery Systems Inc., under ANDA 077449.